A specific activator of a GIRK4-containing subunit in the central nervous system could be desirable for modulating late-onset obesity, whereas in the periphery, an activator would be desirable for PA and an inhibitor for reducing AF. The gene discussed is KCNJ5; the disease is obesity due to melanocortin 4 receptor deficiency.